Gene Therapy
New Gene Therapy Study Findings Recently Were Reported by Researchers at Mayo Clinic
Published in Gene Therapy Weekly, April 19th, 2012
2012 APR 19 -- "Oncolytic measles virus (MV) encoding the human thyroidal sodium iodide symporter (MV-NIS) has proved to be safe after intraperitoneal or intravenous administration in patients with ovarian cancer or multiple myeloma, respectively, but it has not yet been administered through intratumoral injection in humans. Squamous cell carcinoma (SCC) of the head and neck (SCCHN) usually is locally invasive and spreads to the cervical lymph nodes, which are suitable for the intratumoral administration of oncolytic viruses," investigators in Rochester, Minnesota report.
"To test whether oncolytic MV is an effective treatment for SCCHN, we used oncolytic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2012-04-19)
More Articles from Gene Therapy Weekly
- Gene Therapy
Researchers from University of Calgary Detail New Studies and Findings in the Area of Gene Therapy - Gene Therapy
Researchers from University of Pittsburgh Detail New Studies and Findings in the Area of Gene Therapy - Gene Therapy
Studies Conducted at University of California on Gene Therapy Recently Published - Gene Therapy
New Gene Therapy Data Have Been Reported by Investigators at University of Bern - Gene Therapy
New Findings Reported from University of Michigan Describe Advances in Gene Therapy - Immunoglobulins
Investigators from Auburn University Release New Data on Immunoglobulins - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
